Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 121 Records) |
| Query Trace: Disease Progression and Braf[original query] |
|---|
| Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma. JCO precision oncology 2022 08 6 e2100504. Wang Jennifer Rui, Montierth Matthew, Xu Li, Goswami Maitrayee, Zhao Xiao, Cote Gilbert, Wang Wenyi, Iyer Priyanka, Dadu Ramona, Busaidy Naifa L, Lai Stephen Y, Gross Neil D, Ferrarotto Renata, Lu Charles, Gunn Gary Brandon, Williams Michelle D, Routbort Mark, Zafereo Mark E, Cabanillas Maria |
| A Targeted Next-Generation Sequencing Panel to Genotype Gliomas. Life (Basel, Switzerland) 2022 Jun 12 (7): . Guarnaccia Maria, Guarnaccia Laura, La Cognata Valentina, Navone Stefania Elena, Campanella Rolando, Ampollini Antonella, Locatelli Marco, Miozzo Monica, Marfia Giovanni, Cavallaro Sebastia |
| Genetic correlation of crizotinib efficacy and resistance in ALK- rearranged non-small-cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2022 7 171 18-25. Liu Chang, Liu Cuicui, Liao Jiatao, Yin Jiani C, Wu Xianghua, Zhao Xinmin, Sun Si, Wang Huijie, Hu Zhihuang, Zhang Yao, Yu Hui, Shao Yang, Wang Jial |
| Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration-resistant prostate cancer. The Prostate 2022 6 82 (13): 1264-1272. Bray Alexander W, Duan Rong, Malalur Pannaga, Drusbosky Leylah M, Gourdin Theodore S, Hill Elizabeth G, Lilly Michael |
| Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2022 Jun . Aparicio Jorge, Virgili Manrique Anna C, Capdevila Jaume, Muñoz Boza Félix, Galván Patricia, Richart Paula, Oliveres Helena, Páez David, Hernando Jorge, Serrano Sara, Vera Ruth, Hernandez-Yagüe Xavier, Gallego Rafael Álvarez, Riesco-Martinez M Carmen, García de Albeniz Xavier, Maurel Jo |
| Molecular mechanisms underlying the resistance of BRAF V600E-mutant metastatic colorectal cancer to EGFR/BRAF inhibitors. Therapeutic advances in medical oncology 2022 6 14 17588359221105022. Xu Ting, Wang Xicheng, Wang Zhenghang, Deng Ting, Qi Changsong, Liu Dan, Li Yanyan, Ji Congcong, Li Jian, Shen L |
| Therapeutic impact of determination of RAS mutations in the plasma of patient with colorectal cancer. Gastroenterology and hepatology from bed to bench 2022 5 15 (1): 93-98. Macedo F, Monteiro J, Pereira T Cunha, Monteiro A R, Felix Soares R, Bonito N, Sousa |
| Treatments after second progression in metastatic colorectal cancer: A pooled analysis of the TRIBE and TRIBE2 studies. European journal of cancer (Oxford, England : 1990) 2022 May 170 64-72. Rossini Daniele, Germani Marco M, Lonardi Sara, Pietrantonio Filippo, Dell'Aquila Emanuela, Borelli Beatrice, Allegrini Giacomo, Maddalena Giulia, Randon Giovanni, Marmorino Federica, Zaniboni Alberto, Buonadonna Angela, Boccaccino Alessandra, Conca Veronica, Antoniotti Carlotta, Passardi Alessandro, Masi Gianluca, Cremolini Chia |
| The Role of Treatment Sequencing with Immune-Checkpoint Inhibitors and BRAF/MEK Inhibitors for Response and Survival of Patients with BRAFV600-Mutant Metastatic Melanoma-A Retrospective, Real-World Cohort Study. Cancers 2022 5 14 (9): . Haist Maximilian, Stege Henner, Ebner Ronja, Fleischer Maria Isabel, Loquai Carmen, Grabbe Steph |
| Clinical Utility of Genomic Profiling Tests in Patients with Advanced Gastrointestinal Cancers. Targeted oncology 2022 4 17 (2): 177-185. Takeda Hiroyuki, Imoto Kiyomi, Umemoto Kumiko, Doi Ayako, Arai Hiroyuki, Horie Yoshiki, Mizukami Takuro, Oguri Tomoyo, Ogura Takashi, Izawa Naoki, Yamamoto Hiroyuki, Yamano Yoshihisa, Sunakawa |
| Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 4 40 (20): 2235-2245. Eckstein Olive S, Allen Carl E, Williams P Mickey, Roy-Chowdhuri Sinchita, Patton David R, Coffey Brent, Reid Joel M, Piao Jin, Saguilig Lauren, Alonzo Todd A, Berg Stacey L, Ramirez Nilsa C, Jaju Alok, Mhlanga Joyce, Fox Elizabeth, Hawkins Douglas S, Mooney Margaret M, Takebe Naoko, Tricoli James V, Janeway Katherine A, Seibel Nita L, Parsons D Willia |
| BRAF Mutations in Low-Grade Serous Ovarian Cancer and Response to BRAF Inhibition. JCO precision oncology 2022 2 2 1-14. Moujaber Tania, Etemadmoghadam Dariush, Kennedy Catherine J, Chiew Yoke-Eng, Balleine Rosemary L, Saunders Catherine, Wain Gerard V, Gao Bo, Hogg Russell, Srirangan Sivatharsny, Kan Casina, Fereday Sian, Traficante Nadia, , Patch Ann-Marie, Pearson John V, Waddell Nicola, Grimmond Sean M, Dobrovic Alexander, Bowtell David D L, Harnett Paul R, deFazio An |
| Effects of BRAF V600E and NRAS mutational status on the progression-free survival and clinicopathological characteristics of patients with melanoma. Oncology letters 2023 Jan 25 (1): 27. Zablocka Tatjana, Kreismane Madara, Pjanova Dace, Isajevs Serge |
| Dynamic Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer. JCO precision oncology 2023 9 7 e2200694. Milena Urbini, Giorgia Marisi, Irene Azzali, Giulia Bartolini, Elisa Chiadini, Laura Capelli, Gianluca Tedaldi, Davide Angeli, Matteo Canale, Chiara Molinari, Francesca Rebuzzi, Alessandra Virga, Andrea Prochowski Iamurri, Laura Matteucci, Francesco Giulio Sullo, Silvia Angela Debonis, Chiara Gallio, Giovanni Luca Frassineti, Giovanni Martinelli, Paola Ulivi, Alessandro Passar |
| BRAF-MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas. The New England journal of medicine 2023 7 389 (2): 118-126. Priscilla K Brastianos, Erin Twohy, Susan Geyer, Elizabeth R Gerstner, Timothy J Kaufmann, Shervin Tabrizi, Brian Kabat, Julia Thierauf, Michael W Ruff, Daniela A Bota, David A Reardon, Adam L Cohen, Macarena I De La Fuente, Glenn J Lesser, Jian Campian, Pankaj K Agarwalla, Priya Kumthekar, Bhupinder Mann, Shivangi Vora, Michael Knopp, A John Iafrate, William T Curry, Daniel P Cahill, Helen A Shih, Paul D Brown, Sandro Santagata, Fred G Barker, Evanthia Galan |
| Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial. JAMA oncology 2023 5 . Stefania Napolitano, Vincenzo De Falco, Giulia Martini, Davide Ciardiello, Erika Martinelli, Carminia Maria Della Corte, Lucia Esposito, Vincenzo Famiglietti, Alessandra Di Liello, Antonio Avallone, Claudia Cardone, Alfonso De Stefano, Vincenzo Montesarchio, Maria Giulia Zampino, Roberto Bordonaro, Mario Scartozzi, Daniele Santini, Massimo Di Maio, Ferdinando De Vita, Lucia Altucci, Francesca Marrone, Fortunato Ciardiello, Teresa Troia |
| Genomic landscape and survival analysis of ctDNA "neo-RAS wild-type" patients with originally RAS mutant metastatic colorectal cancer. Frontiers in oncology 2023 4 13 1160673. Nicolazzo Chiara, Magri Valentina, Marino Luca, Belardinilli Francesca, Di Nicolantonio Federica, De Renzi Gianluigi, Caponnetto Salvatore, De Meo Michela, Giannini Giuseppe, Santini Daniele, Cortesi Enrico, Gazzaniga Pao |
| Circulating Tumor DNA Dynamics and Treatment Outcome of Regorafenib in Metastatic Colorectal Cancer. Cancer research and treatment 2023 3 . Lee Dae-Won, Lim Yoojoo, Kim Hwang-Phill, Kim Su Yeon, Roh Hanseong, Kang Jun-Kyu, Lee Kyung-Hun, Kim Min Jung, Ryoo Seung-Bum, Park Ji Won, Jeong Seung-Yong, Park Kyu Joo, Kang Gyeong Hoon, Han Sae-Won, Kim Tae-Y |
| Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 11 JCO2301838. Daphne A Haas-Kogan, Mariam S Aboian, Jane E Minturn, Sarah E S Leary, Mohamed S Abdelbaki, Stewart Goldman, Jennifer D Elster, Adam Kraya, Matthew R Lueder, Divya Ramakrishnan, Marc von Reppert, Kevin X Liu, Jo Lynne Rokita, Adam C Resnick, David A Solomon, Joanna J Phillips, Michael Prados, Annette M Molinaro, Sebastian M Waszak, Sabine Muell |
| BRAF + EGFR +/- MEK inhibitors after immune checkpoint inhibitors in BRAF V600E mutated and deficient mismatch repair or microsatellite instability high metastatic colorectal cancer. European journal of cancer (Oxford, England : 1990) 2024 8 210 114290. Margherita Ambrosini, David Tougeron, Dominik Modest, Rosine Guimbaud, Scott Kopetz, Marie Decraecker, Stefano Kim, Clelia Coutzac, Geraldine Perkins, Emily Alouani, Federica Marmorino, Simon Pernot, Frank A Sinicrope, Elena Elez, Pauline Parent, Chiara Cremolini, Filippo Pietrantonio, Sara Lonardi, Claire Gallois, Julien Tai |
| Molecular profiling of low-risk papillary thyroid carcinoma (mPTC) on active surveillance. The Journal of clinical endocrinology and metabolism 2024 8 . Teresa Ramone, Arianna Ghirri, Alessandro Prete, Antonio Matrone, Raffaele Ciampi, Paolo Piaggi, Maria Scutari, Teresa Rago, Liborio Torregrossa, Cristina Romei, Rossella Elisei, Eleonora Molina |
| BRAF-V600E mutations in plasma and peripheral blood mononuclear cells correlate with prognosis of pediatric Langerhans cell histiocytosis treated with first-line therapy. Pediatric blood & cancer 2024 6 e31099. Chan-Juan Wang, Ting Zhu, Chen-Zi Zhao, Hua Cui, Dong Wang, Zi-Jing Zhao, Xiao-Tong Huang, Hua-Lin Li, Fei-Fei Liu, Rui Zhang, Zhi-Gang Li, Lei C |
| Exploring RAS mutation incidence and temporal heterogeneity in metastatic colorectal cancer patients - a single-institution experience utilising circulating tumour DNA. Contemporary oncology (Poznan, Poland) 2024 5 28 (1): 45-50. George Zarkavelis, Anna Lea Amylidi, Nanteznta Torounidou, Melina Yerolatsite, Athanasia Keravasili, Varvara Keramisanou, Davide Mau |
| BRAF mutation in myeloid neoplasm: incidences and clinical outcomes. Leukemia & lymphoma 2024 5 1-6. Tareq Abuasab, Shehab Mohamed, Naveen Pemmaraju, Tapan M Kadia, Naval Daver, Courtney D DiNardo, Farhad Ravandi, Wei Qiao, Guillermo Montalban-Bravo, Gautam Borthak |
| Personalized therapy guided by longitudinal liquid biopsies for treatment of leptomeningeal disease from lung adenocarcinoma: A case report. Oncology letters 2024 5 28 (1): 299. Mingyao Lai, Tianhao Mu, Ming Liu, Qingjun Hu, Juan Li, Tanxiao Huang, Yingmei Li, Shifu Chen, Linbo C |
| Monitoring ctDNA RAS Mutational Status in Metastatic Colorectal Cancer: A Trial Protocol of RAS-trace and RAS-trace-2 Studies. Journal of the anus, rectum and colon 2024 5 8 (2): 132-136. Kozo Kataoka, Takeshi Yamada, Manabu Shiozawa, Naoto Takase, Kazuma Ito, Kentaro Yamazaki, Jun Watanabe, Toshihiro Kudo, Takeshi Suto, Toshihiko Matsumoto, Kohei Murata, Yusuke Suwa, Shogen Boku, Hisateru Yasui, Nobuhisa Matsuhashi, Atsuyuki Maeda, Kiichi Sugimoto, Yusuke Matsumoto, Mitsuru Yokota, Johannes Fredebohm, Keita Mori, Masataka Ike |
| The prognostic value of tumor-infiltrating lymphocytes in vulvovaginal melanoma. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2024 11 . Margaux Vanbockstael, Guillaume Bataillon, Mathilde Morisseau, Gwenael Ferron, Justine Attal, Thomas Meresse, Emilie Tournier, Yann Tanguy Le Gac, Cécile Pages, Alejandra Martin |
| Circulating tumor DNA in conjunctival melanoma: landscape and surveillance value. American journal of ophthalmology 2024 10 . Hao Tian, Hanhan Shi, Jie Chen, Tianyu Zhu, Ziyue Huang, Chunyan Zong, Shichong Jia, Jing Ruan, Shengfang Ge, Haihua Yuan, Yanjie Zhang, Bin Jiang, Rong Liu, Renbing Jia, Xianqun Fan, Shiqiong |
| Molecular Profiling of Low-Grade Appendiceal Mucinous Neoplasms (LAMN). Genes, chromosomes & cancer 2024 10 63 (10): e23270. Julia Doll, Katja Maurus, Franziska Köhler, Niels Matthes, Johan F Lock, Christoph-Thomas Germer, Andreas Rosenwald, Armin Wiegeri |
| TERT promoter mutations contribute to adverse clinical outcomes and poor prognosis in radioiodine refractory differentiated thyroid cancer. Scientific reports 2024 10 14 (1): 23719. Gongxun Tan, Bingquan Jin, Xiaoqin Qian, Yuguo Wang, Guoliang Zhang, Enock Adjei Agyekum, Feng Wang, Liang Shi, Yue Zhang, Zhenwei Mao, Chunhe Shi, Ying Xu, Xiuying Li, Lele Zhang, Shaohua |
- Page last reviewed:Feb 1, 2024
- Content source: